Some are FDA-approved anti-obesity medications, and others are FDA-approved for other conditions and prescribed off-label to help people lose weight
Amylin has receptors in the kidney so the possibility of a direct effect on the kidney is very real
This is an advanced strategy that requires already having a solid baseline protocol established, but it demonstrates the flexibility that understanding pharmacokinetics provides
Clinical trials have shown that maximal weight loss with GLP-1 drugs is not achieved until about one year and it may be that some people wish to see a more rapid response
However, if tirzepatide has lowered your blood sugar significantly or caused anemia-like symptoms (fatigue, shortness of breath), inform the screener immediately
Lanfer A, Knof K, Barba G, Veidebaum T, Papoutsou S, de Henauw S, et al